Bangladesh HEARTS: Lessons Learned from a National Hypertension Control Program, 2018-2026.
5 affiliations
- 1National Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.
- 2Ministry of Health and Family Welfare, Dhaka, Bangladesh.
- 3Columbia University Irving Medical Center, NY, USA.
- 4Resolve to Save Lives, New York, NY, USA.
- 5University of California at San Francisco, San Francisco, California, USA.
Abstract
To improve hypertension control and prevent cardiovascular disease in Bangladesh, the National Heart Foundation of Bangladesh and Resolve to Save Lives collaborated with the Ministry of Health and Family Welfare to launch the Bangladesh Hypertension Control Initiative (BHCI). The BHCI implemented the WHO-HEARTS hypertension control package in four primary health care facilities (Upazila Health Complexes or UHCs) in 2018, then scaled up to 51 UHCs in 2021, 172 UHCs by 2024, and 320 UHCs by May 2026, covering about 54 million of 108 million adults (~43% coverage). By May 2026, the BHCI had enrolled 739,057 hypertensive patients and achieved 59% blood pressure (BP) control (<140/90 mmHg based on BP measured in the prior three months among all enrolled patients). The BHCI is a scalable model for hypertension control programs in other low- and middle-income countries. For sustained high-quality national scale-up, uninterrupted supply of medicines by the government and accurate information systems are crucial.
Related
- The Impermanence of Public Health Gains—Lessons Learned from Measles Resurgence, Bangladesh, 2026
- Generating Implementation Research Knowledge for Scaling Lifestyle Modification Intervention to Control Hypertension and Diabetes: Lessons from the CoCo-HD Study in Kerala
- Technical evolution of totally endoscopic coronary artery bypass on the da Vinci Xi platform: Lessons learned from the first 84 cases
- Lessons Learned: Digital Epidemiology of Eosinophilic Esophagitis and What Google Trends Reveals
- Vaccine attitudes and perceptions in a post-COVID Era: what lessons can be learned in Tunisia?
BibTeX
@article{jubayer2026bangladesh,
title = {{Bangladesh HEARTS: Lessons Learned from a National Hypertension Control Program, 2018-2026.}},
author = {Shamim Jubayer and Md Ahsan-Uz-Zaman and Syed Zakir Hossain and Mahfuzur Rahman Bhuiyan and Obehioye Aimiosior and Ahmad Abrar and Rahat Iqbal Chowdhury and Mohammad Robed Amin and Bolanle F Banigbe and Reena Gupta and Andrew E Moran and Thomas R Frieden and SohelReza Choudhury},
journal = {Global heart},
year = {2026},
month = oct,
doi = {10.5334/gh.1595},
url = {https://europepmc.org/article/MED/42921236},
note = {CC BY},
}
RIS
TY - JOUR
TI - Bangladesh HEARTS: Lessons Learned from a National Hypertension Control Program, 2018-2026.
AU - Shamim Jubayer
AU - Md Ahsan-Uz-Zaman
AU - Syed Zakir Hossain
AU - Mahfuzur Rahman Bhuiyan
AU - Obehioye Aimiosior
AU - Ahmad Abrar
AU - Rahat Iqbal Chowdhury
AU - Mohammad Robed Amin
AU - Bolanle F Banigbe
AU - Reena Gupta
AU - Andrew E Moran
AU - Thomas R Frieden
AU - SohelReza Choudhury
PY - 2026
DA - 2026/10/21
JO - Global heart
DO - 10.5334/gh.1595
UR - https://europepmc.org/article/MED/42921236
AB - To improve hypertension control and prevent cardiovascular disease in Bangladesh, the National Heart Foundation of Bangladesh and Resolve to Save Lives collaborated with the Ministry of Health and Family Welfare to launch the Bangladesh Hypertension Control Initiative (BHCI). The BHCI implemented the WHO-HEARTS hypertension control package in four primary health care facilities (Upazila Health Complexes or UHCs) in 2018, then scaled up to 51 UHCs in 2021, 172 UHCs by 2024, and 320 UHCs by May 2026, covering about 54 million of 108 million adults (~43% coverage). By May 2026, the BHCI had enrolled 739,057 hypertensive patients and achieved 59% blood pressure (BP) control (<140/90 mmHg based on BP measured in the prior three months among all enrolled patients). The BHCI is a scalable model for hypertension control programs in other low- and middle-income countries. For sustained high-quality national scale-up, uninterrupted supply of medicines by the government and accurate information systems are crucial.
SN - 2211-8160
SN - 2211-8179
ER -